Technologies related to Rare Diseases

Blood-Based Assay for the Diagnosis and Monitoring of Hyposialylation Disorders
Ref: E-056-2013/0 | Updated: Sep 14, 2017
Blood-Based Assay for the Diagnosis and Monitoring of Hyposialylation Disorders
Ref: E-056-2013-0 | Updated: Jun 11, 2019
Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and Other Proteinopathies
Ref: E-144-2012-0 | Updated: May 1, 2018
Small-Molecule Inhibitors of Human Galactokinase for the Treatment of Galactosemia and Cancers
Ref: E-240-2011-0 | Updated: Apr 20, 2016
Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid as a Therapeutic Agent for Increasing Sialylation in Certain Muscular Atrophies, Kidney Disorders, Cancers or Poor Immune Function
Ref: E-270-2011/0 | Updated: Sep 21, 2015
Multivalent Vaccines for Rabies Virus and Filoviruses
Ref: E-032-2011-0 | Updated: May 7, 2018
Monoclonal Antibodies for Rare Diseases
Ref: E-039-2011-0 | Updated: May 3, 2016
Use of Anthrax Lethal Factor to Treat Cancer and Screening Methods for MAPK Kinase Protease Activity
Ref: E-066-1998-0 | Updated: Nov 20, 2013
Development of Dengue Virus Type 3 Vaccine Candidates
Ref: E-139-2006-0 | Updated: May 9, 2016
Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines
Ref: E-268-2002-0 | Updated: Sep 1, 2008
Aquaporin 2 Polyclonal Antibodies
Ref: E-045-2008-0 | Updated: Dec 1, 2007
Model for Study of Glomerular Disorders: Conditionally-Immortalized Mouse Podocyte Cell Line with Tet-on-Regulated Gene Expression
Ref: E-049-2007-0 | Updated: May 14, 2018
Vaccine Production Strain for Acellular Pertussis Vaccine
Ref: E-159-1999-0 | Updated: Sep 16, 2015
MEN1, The Gene For Multiple Endocrine Neoplasia Type 1
Ref: E-094-1997/0 | Updated: Aug 1, 1997
Subscribe to Technologies related to Rare Diseases